Travere Therapeutics recently reached a new 52-week high after investors reacted to regulatory updates for its rare kidney disease therapy FILSPARI, including the removal of an FDA advisory committee ...
Get the live share price of DaVita HealthCare Partners Inc (DVA), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
MLYS, LYEL, NKTR and INSM rise more than 50% in 2025 as clinical wins, FDA approvals and M&A deals revive sector momentum heading into 2026.
Get the live share price of AstraZeneca PLC ADR (AZN), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
FDA approves FUROSCIX- for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 ...
Vertex Pharmaceuticals (VRTX) just checked several big boxes at once, with upbeat pediatric data for CASGEVY, fresh momentum in its kidney disease program, and a wave of investor interest following ...
Renalytix PLC ADR advanced stock charts by Barron's. View RNLXD historical stock data and compare to other stocks, and exchanges.
NORTHAMPTON, MA / ACCESS Newswire / December 22, 2025 / DaVita:For individuals managing chronic kidney disease (CKD), dietary ...
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...
Following this week's European Commission approval of Roche/Genentech's Gazyvaro (obinutuzumab) for the treatment of lupus nephritis (LN), Spherix Global Insights' latest RealTime Dynamix(TM): Lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback